Risks and benefits of azathioprine therapy.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16009676.
- Also identified by PMC identifier 1774869.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The risk of lymphoma may be increased by about fourfold in patients with inflammatory bowel disease treated with thiopurines. The increased risk could be a result of the medications, the severity of the underlying disease, or a combination of the two.
Medical subject headings
- Antimetabolites
- Azathioprine
- Inflammatory Bowel Diseases
- Lymphoma